相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Discovery of the Macrocycle 11-(2-Pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene (SB1518), a Potent Janus Kinase 2/Fms-Like Tyrosine Kinase-3 (JAK2/FLT3) Inhibitor for the Treatment of Myelofibrosis and Lymphoma
Anthony D. William et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
The current status and the future of JAK2 inhibitors for the treatment of myeloproliferative diseases
Yasumichi Hitoshi et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2010)
Structural and Thermodynamic Characterization of the TYK2 and JAK3 Kinase Domains in Complex with CP-690550 and CMP-6
Jill E. Chrencik et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Phenylaminopyrimidines as inhibitors of Janus kinases (JAKs)
Christopher J. Burns et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Prospect of JAK2 inhibitor therapy in myeloproliferative neoplasms
Ehab Atallah et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2009)
Dissecting Specificity in the Janus Kinases: The Structures of JAK-Specific Inhibitors Complexed to the JAK1 and JAK2 Protein Tyrosine Kinase Domains
Neal K. Williams et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
JAK2 Inhibitors: A Reality? A Hope?
Effrosyni Apostolidou et al.
CLINICAL LYMPHOMA & MYELOMA (2009)
Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders
Ross L. Levine et al.
NATURE REVIEWS CANCER (2007)
Recent advances in the bcr-abl negative chronic myeloproliferative diseases
Michael Bennett et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2006)
Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders
Robert Kralovics et al.
BLOOD (2006)
V617F mutation in JAK2 is associated idiopathic myelofibrosis
PJ Campbell et al.
BLOOD (2006)
The structural basis of Janus kinase 2 inhibition by a potent and specific pan-Janus kinase inhibitor
IS Lucet et al.
BLOOD (2006)
Molecular basis of the diagnosis and treatment of polycythemia vera and essential thrombocythemia
Andrew I. Schafer
BLOOD (2006)
Crystal structure of the Jak3 kinase domain in complex with a staurosporine analog
TJ Boggon et al.
BLOOD (2005)
The JAK/STAT signaling pathway
JS Rawlings et al.
JOURNAL OF CELL SCIENCE (2004)
The structural basis for autoinhibition of FLT3 by the juxtamembrane domain
J Griffith et al.
MOLECULAR CELL (2004)
ExPASy: the proteomics server for in-depth protein knowledge and analysis
E Gasteiger et al.
NUCLEIC ACIDS RESEARCH (2003)
Multiple sequence alignment with the Clustal series of programs
R Chenna et al.
NUCLEIC ACIDS RESEARCH (2003)
Improving the prediction of protein secondary structure in three and eight classes using recurrent neural networks and profiles
G Pollastri et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2002)
Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides
GA Kaminski et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2001)
The Protein Data Bank
HM Berman et al.
NUCLEIC ACIDS RESEARCH (2000)
分享论文
